- Home
- MCR vs STIM Comparison
MCR vs STIM Comparison
Compare MCR & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCR
- STIM
- Stock Information
- Founded
- MCR 1989
- STIM 2003
- Country
- MCR United States
- STIM United States
- Employees
- MCR N/A
- STIM N/A
- Industry
- MCR Trusts Except Educational Religious and Charitable
- STIM Medical/Dental Instruments
- Sector
- MCR Finance
- STIM Health Care
- Exchange
- MCR Nasdaq
- STIM Nasdaq
- Market Cap
- MCR 266.0M
- STIM 232.3M
- IPO Year
- MCR N/A
- STIM 2018
- Fundamental
- Price
- MCR $6.01
- STIM $4.07
- Analyst Decision
- MCR
- STIM Buy
- Analyst Count
- MCR 0
- STIM 4
- Target Price
- MCR N/A
- STIM $6.00
- AVG Volume (30 Days)
- MCR 66.7K
- STIM 1.1M
- Earning Date
- MCR 01-01-0001
- STIM 05-06-2025
- Dividend Yield
- MCR 8.52%
- STIM N/A
- EPS Growth
- MCR N/A
- STIM N/A
- EPS
- MCR 0.38
- STIM N/A
- Revenue
- MCR N/A
- STIM $74,890,000.00
- Revenue This Year
- MCR N/A
- STIM $102.36
- Revenue Next Year
- MCR N/A
- STIM $9.83
- P/E Ratio
- MCR $16.61
- STIM N/A
- Revenue Growth
- MCR N/A
- STIM 4.96
- 52 Week Low
- MCR $5.63
- STIM $0.52
- 52 Week High
- MCR $6.70
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- MCR 38.98
- STIM 52.49
- Support Level
- MCR $5.96
- STIM $3.58
- Resistance Level
- MCR $6.07
- STIM $4.14
- Average True Range (ATR)
- MCR 0.12
- STIM 0.40
- MACD
- MCR -0.00
- STIM 0.03
- Stochastic Oscillator
- MCR 56.13
- STIM 90.22
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income. The fund invests the assets in debt instruments. It invests the assets in corporate bonds of U.S. and foreign issuers, U.S. Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S. and foreign issuers, and debt instruments of issuers located in emerging market countries.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.